Sverker Hasselblom

Summary

Affiliation: Sahlgrenska University Hospital
Country: Sweden

Publications

  1. ncbi The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphoma
    Sverker Hasselblom
    Section of Haematology and Coagulation, Department of Internal Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Br J Haematol 137:364-73. 2007
  2. ncbi The impact of gender, age and patient selection on prognosis and outcome in diffuse large B-cell lymphoma - a population-based study
    Sverker Hasselblom
    Department of Medicine, Section of Haematology and Coagulation, Sahlgrenska University Hospital, Goteborg, Sweden
    Leuk Lymphoma 48:736-45. 2007
  3. doi Low rather than high Ki-67 protein expression is an adverse prognostic factor in diffuse large B-cell lymphoma
    Sverker Hasselblom
    Department of Internal Medicine, Section of Haematology and Coagulation, Goteborg, Sweden
    Leuk Lymphoma 49:1501-9. 2008
  4. doi High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
    Sverker Hasselblom
    Section of Haematology and Coagulation, Department of Internal Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden
    Br J Haematol 149:560-8. 2010
  5. doi Expression of CD68+ tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosis
    Sverker Hasselblom
    Section of Haematology and Coagulation, Department of Internal Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Pathol Int 58:529-32. 2008
  6. doi Improved outcome for very elderly patients with diffuse large B-cell lymphoma in the immunochemotherapy era
    Sverker Hasselblom
    Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Leuk Lymphoma 53:394-9. 2012
  7. ncbi Testicular lymphoma--a retrospective, population-based, clinical and immunohistochemical study
    Sverker Hasselblom
    Haematology and Coagulation Section, Department of Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Acta Oncol 43:758-65. 2004
  8. ncbi Evaluation of clinical staging in chronic lymphocytic leukemia- population-based study
    Peter Apelgren
    Section of Haematology and Coagulation, Department of Internal Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Leuk Lymphoma 47:2505-16. 2006
  9. ncbi The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL)
    Katarina Junevik
    Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Ann Hematol 86:89-94. 2007

Collaborators

  • Hans Wedel
  • Katarina Junevik
  • Herman Nilsson-Ehle
  • Per Ola Andersson
  • Olle Werlenius
  • Peter Apelgren
  • Stefan Jacobsson

Detail Information

Publications9

  1. ncbi The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphoma
    Sverker Hasselblom
    Section of Haematology and Coagulation, Department of Internal Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Br J Haematol 137:364-73. 2007
    ..The lack of correlation between the number of FOXP3+ cells and survival could possibly indicate that tumour-infiltrating T(regs) are of less clinical importance in DLBCL. However, these findings need to be explored in functional studies...
  2. ncbi The impact of gender, age and patient selection on prognosis and outcome in diffuse large B-cell lymphoma - a population-based study
    Sverker Hasselblom
    Department of Medicine, Section of Haematology and Coagulation, Sahlgrenska University Hospital, Goteborg, Sweden
    Leuk Lymphoma 48:736-45. 2007
    ..As men had lower PFS and OS than women, it seems important that gender perspective be taken into account in future studies...
  3. doi Low rather than high Ki-67 protein expression is an adverse prognostic factor in diffuse large B-cell lymphoma
    Sverker Hasselblom
    Department of Internal Medicine, Section of Haematology and Coagulation, Goteborg, Sweden
    Leuk Lymphoma 49:1501-9. 2008
    ..Together, these results suggest that low rather than high Ki-67 protein expression is of prognostic importance in DLBCL...
  4. doi High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
    Sverker Hasselblom
    Section of Haematology and Coagulation, Department of Internal Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden
    Br J Haematol 149:560-8. 2010
    ..In addition, bcl-2 status could have prognostic importance also in the era of immunochemotherapy...
  5. doi Expression of CD68+ tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosis
    Sverker Hasselblom
    Section of Haematology and Coagulation, Department of Internal Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Pathol Int 58:529-32. 2008
    ..94). These data indicate that the pro-tumor effect of TAM has limited clinical relevance in DLBCL patients, which could imply that therapeutic strategies aimed at enhancing their anti-tumor activity are of continuous clinical interest...
  6. doi Improved outcome for very elderly patients with diffuse large B-cell lymphoma in the immunochemotherapy era
    Sverker Hasselblom
    Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Leuk Lymphoma 53:394-9. 2012
    ..In conclusion, moderately reduced R-CHOP is tolerable and effective for a considerable number of very elderly patients with DLBCL and high age by itself should not be a reason for excluding a patient with DLBCL from such treatment...
  7. ncbi Testicular lymphoma--a retrospective, population-based, clinical and immunohistochemical study
    Sverker Hasselblom
    Haematology and Coagulation Section, Department of Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Acta Oncol 43:758-65. 2004
    ..A high intratumoural microvessel density was correlated with a high degree of Ki-67 positive tumour cells and an inferior overall survival...
  8. ncbi Evaluation of clinical staging in chronic lymphocytic leukemia- population-based study
    Peter Apelgren
    Section of Haematology and Coagulation, Department of Internal Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Leuk Lymphoma 47:2505-16. 2006
    ..Finally, in both systems, low stage patients had inferior survival compared to age- and sex-matched controls. Our data emphasize the need for a new risk stratification system for CLL patients...
  9. ncbi The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL)
    Katarina Junevik
    Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Ann Hematol 86:89-94. 2007
    ..Our results suggest that increased expression of KIR and CD94 on CTL in advanced stage B-CLL may potentially contribute to the impaired anti-tumour immune response in these patients...